,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,192,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,194,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
2,196,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice,Other,,
3,200,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
4,206,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
5,210,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
6,212,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
7,216,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
8,220,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
9,224,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P335 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
10,226,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in B6C3F1 mice,Other,,
11,230,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice,Other,,
12,246,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1081 Chloroleukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
13,248,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
14,250,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
15,252,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in B6D2F1 (BDF1) mice,Other,,
16,256,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
17,258,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice,Other,,
18,260,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
19,264,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
20,268,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1798 Lymphosarcoma (subcutaneous) in CD2F1 (CDF1) mice,Other,,
21,270,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
22,274,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice,Other,,
23,296,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
24,298,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
25,306,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
26,308,1,1,,89195,31010,Active,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to 6-MP and 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice",Other,,
27,314,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1534 Leukemia (intraperitoneal) in DBA/2 mice,Other,,
28,318,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P815 Mast Cell Leukemia (Ascitic) (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
29,328,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
30,330,1,1,,89195,31010,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
31,332,1,1,,89195,31010,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  ADJ-PC-20 Plasma Cell (subcutaneous) in unknown mice,Other,,
32,334,1,1,,89195,31010,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
33,96856,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 10 mice measured as median survival range at 120 mg/kg; Value ranges from(9-15),Other,6620303.0,
34,96858,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 10 mice measured as median survival range at 160 mg/kg; Value ranges from(10-16).,Other,6620303.0,
35,96990,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 5 mice measured as median survival range at 240 mg/kg; Value ranges from(13-18),Other,6620303.0,
36,96991,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 5 mice measured as median survival range at 280 mg/kg; Value ranges from(14-20),Other,6620303.0,
37,97395,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 10 mice measured as Increased life span at 120 mg/kg.,Other,6620303.0,
38,97396,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 10 mice measured as Increased life span at 160 mg/kg.,Other,6620303.0,
39,97401,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 5 mice measured as Increased life span at 240 mg/kg.,Other,6620303.0,
40,97402,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 5 mice measured as Increased life span at 280 mg/kg.,Other,6620303.0,
41,97933,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 11 mice measured as T/C values(days); T/C = 11/9,Other,6620303.0,
42,97937,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 13 mice measured as T/C values(days); T/C = 13/9,Other,6620303.0,
43,97941,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 15 mice measured as T/C values(days); T/C = 15/9,Other,6620303.0,
44,97946,3,4,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 17 mice measured as T/C values(days); T/C = 17/9,Other,6620303.0,
45,110890,3,3,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 120 mg/kg dose for 1 day.,Other,6620303.0,
46,110894,3,3,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 160 mg/kg dose for 1 day.,Other,6620303.0,
47,110896,3,3,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 200 mg/kg dose for 1 day.,Other,6620303.0,
48,110898,3,3,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 240 mg/kg dose for 1 day.,Other,6620303.0,
49,110899,3,3,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 280 mg/kg dose for 1 day.,Other,6620303.0,
50,115972,3,3,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 5 mice measured as Increased life span at 200 mg/kg.,Other,6620303.0,
51,119382,3,3,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 5 mice measured as median survival range at 200 mg/kg; Value ranges from(13-18),Other,6620303.0,
52,121653,3,3,,103207888,31010,Unspecified,,,,,In vivo antitumor activity against L1210 leukemia in 16 mice measured as T/C values(days); T/C = 16/9,Other,6620303.0,
53,124359,3,4,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 120 mg/kg dose for 7 days.,Other,6620303.0,
54,124362,3,4,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 160 mg/kg dose for 7 days.,Other,6620303.0,
55,124363,3,4,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 200 mg/kg dose for 7 days.,Other,6620303.0,
56,124482,3,4,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 240 mg/kg dose for 7 days.,Other,6620303.0,
57,124483,3,4,,103207888,31010,Unspecified,,,,,Average weight of the mouse after treating with 280 mg/kg dose for 7 days.,Other,6620303.0,
